Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China
· Delayed Price · Currency is CNY 9.58
-0.09 (-0.91%)
At close: Apr 28, 2026
SHE:301301 Revenue
Yili Chuanning Biotechnology had revenue of 1.09B CNY in the quarter ending March 31, 2026, a decrease of -15.61%. This brings the company's revenue in the last twelve months to 4.41B, down -20.21% year-over-year. In the year 2025, Yili Chuanning Biotechnology had annual revenue of 4.62B, down -19.83%.
Revenue (ttm)
4.41B
Revenue Growth
-20.21%
P/S Ratio
4.93
Revenue / Employee
1.41M
Employees
3,126
Market Cap
21.74B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xiamen Amoytop Biotech | 3.70B |
| BrightGene Bio-Medical Technology | 1.22B |
| Sinocelltech Group | 1.56B |
| Suzhou Zelgen Biopharmaceuticals | 810.48M |
| Hualan Biological Engineering | 4.49B |
| Beijing Tiantan Biological Products | 6.17B |
| Inner Mongolia Furui Medical Science | 1.60B |
| Jinyu Bio-technology | 1.33B |